US2022034770A1PendingUtilityA1
Sample preparation for difficult sample types
Est. expiryNov 2, 2035(~9.3 yrs left)· nominal 20-yr term from priority
Inventors:Stephanie Anne ThatcherJeremy Paul GreenErik W. HuynhAndrew Clinton HemmertJesse Linton MontgomeryRobert John CrispKendall A. RasbandElizabeth Mary Ott CrowtherCheryl Lynn Baird
C12N 15/1003C12Q 1/6806C12Q 2521/537C12Q 2527/153G01N 2001/4088G01N 2001/028G01N 1/4077C12Q 1/686C12N 15/1006G01N 1/02
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Devices and methods are provided for collecting and handling difficult sample types.
Claims
exact text as granted — not AI-modified1 . A method of amplifying RNA from a direct blood sample comprising:
(a) adding the direct blood sample to a sample buffer, (b) bead beating the sample buffer, (c) extracting the RNA from the sample buffer, and (d) amplifying the RNA.
2 . The method of claim 1 , wherein steps (b) through (d) are performed in a closed sample vessel.
3 . The method of claim 1 , wherein steps (a) through (d) are performed without centrifugation, ethanol precipitation, and DNA digestion.
4 . The method of claim 1 , wherein the RNA is host RNA.
5 . The method of claim 1 , wherein the direct blood sample is collected in a RNA stabilized solution.
6 . The method of claim 1 , wherein the direct blood sample is collected in a non-RNA stabilizing solution.
7 . The method of claim 1 , wherein the direct blood sample is separated prior to step (a) and a blood fraction is used.
8 . The method of claim 1 , further comprising filtering the sample between steps (a) and (b).
9 . The method of claim 1 , wherein the RNA is provided in high copy number.
10 . The method of claim 1 , wherein the RNA is from microorganisms.
11 . The method of claim 1 , further comprising washing the RNA following the extracting step, wherein the washing step comprises no more than three washes.
12 . The method of claim 1 , wherein the sample buffer includes a guanidinium compound.
13 . The method of claim 1 , wherein step (g) includes a first-stage multiplex PCR and a plurality of individual second-stage PCR reactions.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.